![]() Henry Schein Henry Schein is a provider of healthcare products and services to dental and medical practitioners. | ![]() Vivesto Vivesto (formerly known as Oasmia Pharmaceutical) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology. | |
Founding Date | Founding Date 1932 | Founding Date 1990 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Melville, US HQ Sydney, AU Vienna, AT Vilvoorde, BE Niagara On The Lake, CA Prague, CZ Paris, FR see more | Locations Uppsala, SE HQ Solna, SE |
Employees | Employees 25,000 | Employees 4 |
Valuation ($) | Valuation ($) 8.9 b | Valuation ($) 13.6 m |
Financial | ||
Revenue (est.) | Revenue (est.) $13.2b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $9.1b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $4.1b (FY, 2025) | Gross profit N/A |
Net income | Net income $419m (FY, 2025) | Net income (kr34.1m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 250m | Total funding raised $ 19.3m |

Vivesto (formerly known as Oasmia Pharmaceutical) develops, manufactures, markets, and sells drugs in the field of human and veterinary oncology.
View company